Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

NCT01275222 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: RAD001
DRUG: Imatinib 600mg/day (Glevec is the brand name for imatinib)
DRUG: Imatinib 800mg/day (Glevec is the brand name for imatinib)

Sponsor

Novartis Pharmaceuticals